TABLE 2.
Univariate and multivariate analysis of clinical variables
Clinical variable | OR (95% CI) | p value |
---|---|---|
Univariate analysis | ||
PSA | ||
PSA < 10 | Reference | ‐ |
PSA 10.1–19.9 | 1.80 (0.11–12.65) | 0.046 |
PSA 20–49.9 | 2.95 (1.53–29.23) | 0.002 |
PSA > 50 | 28.02 (7.16–98.31) | <0.001 |
T stage | ||
Organ confined | Reference | ‐ |
Locally advanced | 8.54 (2.31–14.24) | <0.001 |
Gleason score | ||
G < 7 | Reference | |
G 3 + 4 | 5.49 (2.74–68.43) | 0.031 |
G 4 + 3 | 12.84 (5.18–94.71) | <0.001 |
G ≥ 8 | 25.72 (6.42–122.16) | <0.001 |
Multivariate analysis | ||
PSA | ||
PSA < 10 | Reference | ‐ |
PSA 10.1–19.9 | 1.1 (0.18–6.31) | 0.62 |
PSA 20–49.9 | 2.08 (0.98–14.17) | 0.042 |
PSA > 50 | 16.52 (5.56–78.31) | <0.001 |
T stage | ||
Organ confined | Reference | ‐ |
Locally advanced | 6.02 (4.21–139.51) | <0.001 |
Gleason score | ||
G < 7 | Reference | ‐ |
G 3 + 4 | 2.04 (0.32–16.47) | 0.0511 |
G 4 + 3 | 4.7 (2.75–32.11) | 0.029 |
G ≥ 8 | 11.32 (3.22–65.75) | <0.001 |